Silvant Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.76M Buy
25,206
+4,408
+21% +$628K 0.1% 116
2025
Q4
$3.46M Buy
20,798
+9,561
+85% +$1.6M 0.12% 103
2025
Q3
$2.2M Buy
+11,237
New +$1.85M 0.08% 122

Other funds holding ALAB

Silvant Capital Management's ALAB Position: Q1 2026 in Review

Silvant Capital Management increased its Astera Labs (ALAB) stake by 21% in Q1 2026, buying an estimated $628K and bringing the position to 25,206 shares worth $2.76M. The position accounts for 0.1% of the portfolio, ranked #116.

Silvant Capital Management first reported a position in ALAB in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.46M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Silvant Capital Management held 25,206 shares of Astera Labs worth $2.76M as of Q1 2026.
  • Silvant Capital Management bought 4,408 Astera Labs shares in Q1 2026, an estimated $628K.
  • Astera Labs made up 0.1% of Silvant Capital Management's portfolio in Q1 2026, its #116 holding.
  • Silvant Capital Management first reported a position in Astera Labs in Q3 2025 and has held it in 3 quarters since.
  • Silvant Capital Management's Astera Labs position peaked at $3.46M in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.